Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04466839
What this trial is testing

Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

Who this might be right for
Parkinson DiseaseCOVID
University Hospital, Toulouse 411
Not applicableStudy completedNCT05198401
What this trial is testing

The Impact of the Previous Exposure to Covid-19 Virus Infection on the Outcome of ICSI Cycles

Who this might be right for
COVID-19IVF
Al Baraka Fertility Hospital 122
Testing effectiveness (Phase 2)Study completedNCT04345601
What this trial is testing

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

Who this might be right for
Sars-CoV2Acute Respiratory Distress SyndromeCOVID-19
Baylor College of Medicine 28
Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Testing effectiveness (Phase 2)Study completedNCT04954469
What this trial is testing

B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency

Who this might be right for
Immune Deficiency Disease
University Hospital Tuebingen 54
Not applicableActive Not RecruitingNCT06755658
What this trial is testing

RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.

Who this might be right for
Infection by SARS-COV-2
Sismanoglio General Hospital 500
Not applicableStudy completedNCT04927078
What this trial is testing

Analysis of Vital Signs in Patients With COVID-19

Who this might be right for
Respiratory Disease
Oxehealth Limited 20
Not applicableStudy completedNCT05881343
What this trial is testing

Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic Surgery

Who this might be right for
Coronavirus InfectionOrthopedic DisorderBone Fracture+2 more
Istituto Ortopedico Rizzoli 40
Not applicableUnknownNCT05362682
What this trial is testing

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Who this might be right for
Sars-CoV-2 Infection
International Vaccine Institute 3,000
Early research (Phase 1)Study completedNCT04932824
What this trial is testing

Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 137
Testing effectiveness (Phase 2)Study completedNCT05576662
What this trial is testing

Paxlovid for Treatment of Long Covid

Who this might be right for
Post-acute Sequelae of SARS-CoV-2 InfectionLong COVID
Stanford University 168
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418
What this trial is testing

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Who this might be right for
COVID-19
Huahui Health 1,200
Not applicableStudy completedNCT05894525
What this trial is testing

Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 8,844
Testing effectiveness (Phase 2)WithdrawnNCT04992247
What this trial is testing

Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

Who this might be right for
Covid19
Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT05640349
What this trial is testing

Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital

Who this might be right for
BacteremiaCatheter-Related Infections
Centre Hospitalier Universitaire de Nice 4,200
Testing effectiveness (Phase 2)Study completedNCT06864143
What this trial is testing

Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

Who this might be right for
InfluenzaSARS-CoV-2
ModernaTX, Inc. 1,320
Testing effectiveness (Phase 2)Study completedNCT05305508
What this trial is testing

Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19.

Who this might be right for
COVID-19 Virus Disease
Hervé SPECHBACH 74
Large-scale testing (Phase 3)Ended earlyNCT04342182
What this trial is testing

Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)

Who this might be right for
COVID-19
Erasmus Medical Center 86
Not applicableStudy completedNCT04347174
What this trial is testing

A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients

Who this might be right for
COVID-19
Cadila Pharnmaceuticals 40
Not applicableStudy completedNCT04916574
What this trial is testing

Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum

Who this might be right for
SARS-COV2 InfectionCovid19
Icosagen Cell Factory 16
Next Page